Stradling advised Viseon Spine in the close of its $5 million Series A financing round. The lead investors were HBM-MedFocus, Invus Opportunities Fund, and affiliates of Wexford Capital LP.
Founded in early 2017 as a spin-off of Stradling client Rebound Therapeutics Corporation, Viseon Spine is an Irvine-based medical device company that uses its proprietary technology comprised of state-of-the-art visualization and illumination technologies to develop single use and disposable devices that improve the procedural and clinical outcomes of minimally invasive spine surgery procedures.